
OpenAI Finalizes $40 Billion Funding Round
Bloomberg's Seth Fiegerman explains OpenAI's complex new funding round that values the company at $300 billion and makes SoftBank the biggest backer of the ChatGPT maker. He speaks with Caroline Hyde on 'Bloomberg Technology.' (Source: Bloomberg)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One
Omada Health (NASDAQ:OMDA) opened its first day of trading with a bangjumping 21% to $23 after pricing its IPO at $19. That move gives the digital chronic-care startup a market cap of roughly $1.3 billion. The $150 million raise was more than just well receivedinvestor demand came in more than 15x oversubscribed, with most allocations going to a concentrated group of institutional buyers. It's another sign that appetite for health-tech IPOs is heating up again. U.S. listings have raised nearly $25 billion year-to-date, and early-stage healthcare names are up an average of 18% since listing. Founded in 2011, Omada offers virtual care between doctor visitsfocused on diabetes, obesity, hypertension, and joint pain. What sets it apart? It's not chasing the GLP-1 gold rush. Instead, Omada supports people already on those drugs, helping them manage side effects, nutrition, and post-treatment maintenance. About 50,000 of its 679,000 members are on GLP-1s. CEO Sean Duffy told Bloomberg that while AI powers much of the back-end, real human interaction is what drives results. Our members tell us they want a personand I have yet to see anyone that feels accountable to ChatGPT, he said. Revenue for Q1 2025 came in just under $55 millionup from $35.1 million a year agowhile net losses narrowed by more than half to $9.4 million. That improving financial picture, combined with a clear niche in chronic care, could be what's drawing top-tier investors. Revelation Partners, Andreessen Horowitz, Fidelity, and USVP are all among the largest shareholders. The IPO was led by Morgan Stanley, Goldman Sachs, and JPMorgan. OMDA now trades on the Nasdaq Global Marketand it's one more sign that digital health might be staging a real comeback. This article first appeared on GuruFocus.
Yahoo
28 minutes ago
- Yahoo
Stargate UAE AI Deal Stalls Over U.S. Chip Rules
AI behemoth Stargate UAE has hit a roadblock because U.S. officials are still hashing out security terms for exporting advanced chips. Nvidia (NASDAQ:NVDA), Oracle (NYSE:ORCL), OpenAI, Cisco Systems (NASDAQ:CSCO), SoftBank Group (SFTBY) and UAE's G42 teamed up last month after President Trump's Middle East stop to launch what could become a 5-gigawatt AI data-center powerhouse. Warning! GuruFocus has detected 4 Warning Signs with NVDA. The first 200-megawatt chunk was supposed to go live in 2026, operated by OpenAI and Oracle, but nobody's signed off on the chip-export rules yet, so the deal remains on ice. Although G42 says the project builds on the new U.S.-UAE AI Acceleration Partnership, which aims to foster safe, responsible AI, Washington still worries about the UAE's China tiesrecalling how the UAE let Huawei (now under U.S. fire) roll out 5G during Trump's first term. OpenAI and G42 both have Microsoft (NASDAQ:MSFT) backing, but even that doesn't erase concerns that Chinese hardware or talent could leak U.S. tech to adversaries. Because of those unresolved security questionslike banning Chinese gear on site or limiting who can work therethe Commerce Department, Nvidia, OpenAI, G42, Microsoft, Oracle and SoftBank all declined to say when any approval might come. And adding drama, Elon Musk recently hinted he might torpedo the whole thing unless xAI gets a seat at the table. Investors should care because if the UAE pushes back on U.S. curbsinsisting on looser rulesthe entire Stargate plan could stall, undermining a high-profile attempt to export American AI clout. Watch for any new U.S. export guidelines and whether Abu Dhabi caves to get those cutting-edge chips; otherwise, this megaproject could sit stalled well past 2026. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
39 minutes ago
- Bloomberg
Broadly Syndicated Loans: market size, structure and historical return profile
Market composition: what's inside the LOAN index? As of April 2025 month-end, the Bloomberg US Leveraged Loan Index included over 1,300 loans from over 1,100 borrowers, with $1.3 trillion in market value. Certain index breakdowns (by % market value) are below: Potential credit diversification Payment rank of BSLs in LOAN Index is secured, with the majority of loans classified as first lien, and may be notable in comparison to high yield bonds (Figure 3), which are often unsecured. Divergence of sub-sector and rating bucket allocation vs. high yield bonds is also noteworthy. For example, the Technology sub-sector makes up 7% of high yield bonds vs. 21% of BSL market (see Figure 4). While B-rated loans make up around 70% of LOAN Index as of April month-end, they comprise less than 40% of the HY Index. Structural differences in payment rank, as well as divergence in composition across sectors and rating buckets, may offer potential credit diversification. Potential risks BSLs are not without risk, however. A rally in interest rates would negatively impact floating-rate coupons, making it less appealing to crossover investors. Further, if holding individual loans, it should be noted that trade settlement times can range from a week to multiple weeks, while bond trades settle in T+1. Finally, Collateralized Loan Obligations (CLOs) hold 65%-70% of the BSL market, and while having a captive investor is generally positive for the BSL market, any material disruption to the CLO market could put stress on the BSL market. Conclusion Floating-rate coupons and consequently strong performance in a high interest rate environment, coupled with secured payment rank and potential credit diversification, are structural traits that can influence how BSLs perform relative to other asset classes.